Thus, JAK2 is functional and normally regulated by chemokines in CLL B-lymphocytes, at least in the group of studied patients and, differently from Rac1 and PIP5K1C [13], appears indispensable for CXCL12-triggered integrin activation. This evidence concerns the gene JAK2 and B-cell chronic lymphocytic leukemia.